Sign up to view injection technique videos, anatomy lectures, and other helpful education for professionals.
Before receiving a sneak a peek at this website injection, tell your doctor if you have ALS ( Lou Gehrig’s disease), myasthenia gravis, Lambert-Eaton syndrome, a breathing disorder, trouble swallowing, facial muscle weakness, a change in the appearance of your face, seizures, bleeding problems, heart disease, if you have had or will have surgery, or if you have ever received other botulinum toxin injections such as Dysport or Myobloc.
BOTOX is not a permanent fix. Results will last for several months – sometimes longer – but they will not last forever. Qualified injectors will tell you there is good news and bad news when it comes to BOTOX. The good news is, if you are not happy with your results, the results will only last a few months. Likewise, the bad news is, if you love your results (which most people do), the results will only last a few months. Regardless, many patients recognize even the temporary results are worth feeling and looking younger.
Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).
Subsequently, in the 1980s, BoNT/A was used for blepharospasm and other focal dystonias8-12. The United States Food and Drug Administration approved BoNT/A (BOTOX®, Allergan, Inc.) in the management of strabismus, blepharospasm and related facial spasms in 1989 and cervical dystonias in 2000. Botulinum toxin type B first became available commercially in the USA in 2000, and was approved for cervical dystonia, but not for blepharospasm or strabismus. Botulinum toxin A is manufactured under the trade name BOTOX® (Allergan, Inc.) in the United States and DYSPORT® (Ipsen Ltd.) in Europe. In the last few years, BoNT/A has also been produced in China. The Chinese toxin (Lanzhou Biological Products Institute, China) is being marketed in Asia as BTX-A. Botulinum toxin B is available in the U.S. as MYOBLOC® and in Europe as NEUROBLOC® (Solstice, Inc.)13-15. A new product based on the purified BoNT/A is now available as Xeomin® from the Merz Company in Germany.
BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in people 18 to 65 years of age. BOTOX® Cosmetic is administered as a simple, nonsurgical treatment that is injected directly into the muscles between the brows. It works by blocking nerve impulses to the injected muscles. This reduces muscle activity that causes moderate to severe lines to form between the brows. Individual results may vary.